Archive for the 'Novel Treatments & Drugs' Category

Novel Treatments & Drugs news feed.

First FDA Approved Treatment for Mesothelioma in 15 Years

In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes became a reality as the

more

Currently Recruiting: Mesothelioma Clinical Trials

When it comes to effective mesothelioma treatments, options are unfortunately limited. There is no cure for mesothelioma and first line chemotherapy treatment Alimta, is no guarantee.  Many who are suffering from mesothelioma, who have found little or no comfort in traditional treatments, may turn to clinical trials for hope.  Through clinical trials, patients have access

more

Survival Factors for Mesothelioma Highlighted by University of Pittsburgh Medical Center

According to GLOBOCAN 2018 statistics, each year there are 30,443 mesothelioma cases worldwide, and of those 30,443, 25,576 pass away.  With close to 85 percent of those diagnosed succumbing to the disease, mesothelioma remains one of the most deadly cancers as there is no cure. However, surviving a mesothelioma diagnosis is not entirely impossible as

more

Phase III Clinical Trial for Mesothelioma Available in 50 Locations Across the Globe

A Phase III clinical trial is now underway in the pivotal study of interferon alfa-2b gene therapy in pleural mesothelioma. After promising results from the Phase II clinical trial, scientists and researchers are hopeful they are just one step away from FDA approval for this cancer treatment that is over 20 years in the making.

more

Targeted Immunotherapy Warrants More Research for Those Suffering from Pleural Mesothelioma

Late last month, the Clinical Respiratory Journal released their findings on the efficacy of intrapleural immunotherapy, which is a highly targeted approach of receiving immunotherapy treatment for those suffering from mesothelioma. Mesothelioma is a cancer caused only by asbestos exposure. Since asbestos is the only known cause, mesothelioma is sometimes referred to as “asbestos cancer.”

more

New Clinical Trial Underway for Immunotherapy Treatment; CA-170

A new immunotherapy treatment that has recently been administered to a patient suffering from mesothelioma has researchers and scientists optimistic that if results are positive, this treatment could be more effective than Keytruda, the immunotherapy treatment that has had major success in non-small cell lung cancer  The name of the treatment is CA-170, and while

more

FDA Approves Genetic-Based Cancer Treatment that Could Help Mesothelioma Patients

Correcting genes that allow cancerous tumors to grow is the basis behind gene therapy, a relatively new treatment that is largely in experimental stages. The initial goals of gene therapy were to address hereditary genetic disorders, but other factors such as the sun, smoking, chemical exposure, etc., can all damage and change our DNA and

more

UK Pharmaceutical Company’s Potential Cancer Vaccine Assists in Treating Mesothelioma

Combination treatment therapies are common for those suffering from mesothelioma because the aggressive nature of this asbestos-caused disease makes it difficult to treat effectively.  Ongoing developments and advancements in medicine have also helped mesothelioma patients extend their life and manage pain throughout the years. While there is no cure for mesothelioma, a recent study published

more

Acupuncture as Potential Palliative Care for Mesothelioma Patients

When one thinks of acupuncture, one may envision a nice relaxing trip to a day spa, where after a long massage or a relaxing facial, tension in body can be further relieved through this ancient practice where thin needles are inserted into the body. However, this traditional Chinese medicine may benefit cancer patients by helping

more

Phase III Clinical Trial for Nintedanib Discontinued After Yielding Negative Results

Disappointing results from the LUME-Phase III clinical trial regarding nintedanib is a setback for scientists and researchers who were hopeful they were on the brink of finding a new, first line treatment for those suffering from mesothelioma. Results from the Phase II clinical trial – published earlier this year – showed promise for the triple

more

Survival Improves in Mesothelioma Patients who Received an Electricity-Based Treatment

The success of a recent Phase II clinical trial in malignant pleural mesothelioma has scientists and researchers excited about the possibility of adding a new treatment that will not only improve survival, but also improve quality of life of the cancer patient. Tumor Treating Fields, which is a therapy that uses alternating electric fields to

more

New Surgical Technique Illuminates Previously Undetected Mesothelioma Tumors

In addition to chemotherapy, radiation therapy, and immunotherapy, those suffering from mesothelioma also have the option for surgery (if they are physically able). Surgery is one of the better options for mesothelioma patients because it can remove most if not all the cancer; however, often times since the cancer is generally diagnosed in the later

more

Metal-based Compound May Reduce Tumor Size in Pleural, Peritoneal Mesothelioma

Mesothelial cells are found in the lining of major organs such as the chest or the abdomen. When asbestos fibers are inhaled or ingested, they slice through the soft tissue and become embedded in the lining of these organs. These fibers cause genetic mutations in the mesothelial cells which then cause the cells to reproduce

more

Potential Breakthrough in Immunotherapy after Nivolumab Study Results

Immunotherapy treatments have once again made headlines, revolutionizing modern medicine and the way we have come to understand cancer treatment. The latest study results published in the American Journal of Case Reports, focuses on Opdivo (nivolumab), a type of check point inhibitor designed to stop immune cells from attacking the healthy cells that are needed

more

Why is Chemotherapy Often Ineffective in Those Suffering from Mesothelioma?

Mesothelioma is a difficult cancer to treat for a multitude of reasons. A mesothelioma diagnosis is rare – only about 3,000 people per year in the United States are diagnosed – and this can make it difficult to study, given that there is generally a very small sample of patients that are able to be

more

Last update: April 01, 2019. 03:30:08 pm.